Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Open Label Study of Abiraterone Acetate (CB7630) and Prednisone in Hormone-Refractory Prostate Cancer
2007-002725-74Phase 2Completed
- Sponsor
- Cougar Biotechnology
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of abiraterone in prostate cancer (PCa), sponsored by Cougar Biotechnology. Primary endpoints: PSA response (≥50% decline) and Safety and tolerability. Started May 2007; status: completed.
02
Drugs
abiraterone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2007-002725-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002725-74.